Practical management of riociguat in patients with pulmonary arterial hypertension

Riociguat is one of several approved therapies available for patients with pulmonary arterial hypertension (PAH). Treatment should be initiated and monitored at an expert center by a physician experienced in treating PAH, and the dose adjusted in the absence of signs and symptoms of hypotension. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Halank, Michael, Tausche, Kristin, Grünig, Ekkehard, Ewert, Ralf, Preston, Ioana R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710674/
https://www.ncbi.nlm.nih.gov/pubmed/31438774
http://dx.doi.org/10.1177/1753466619868938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710674/
https://www.ncbi.nlm.nih.gov/pubmed/31438774
http://dx.doi.org/10.1177/1753466619868938

Ejemplares similares